Home » Topics » Regulatory

Regulatory
RSS

FDA approves Afinitor to treat advanced pancreatic neuroendocrine tumors

May 9, 2011

Revatio approved in E.U. for treatment of pulmonary arterial hypertension in children

May 6, 2011

Boehringer Ingelheim and Lilly receive FDA approval for Tradjenta tablets in type 2 diabetes

May 3, 2011

FDA approves Abbott's AndroGel 1.62% for treatment of men with hypogonadism

May 2, 2011

FDA approves Menactra meningococcal conjugate vaccine for infants

May 2, 2011

FDA approves fixed-dose combination of ibuprofen and famotidine

May 2, 2011

FDA approves Zytiga in combination with prednisone for metastatic CRPC

April 29, 2011

FDA approves additional indication for Lamictal XR

April 29, 2011

Daiichi Sankyo's Lixiana receives first approval in Japan

April 26, 2011

Invega obtains FDA approval for treatment of schizophrenia in adolescents

April 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.